Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.41
- Piotroski Score 3.00
- Grade Buy
- Symbol (OPK)
- Company OPKO Health, Inc.
- Price $1.53
- Changes Percentage (2.35%)
- Change $0.04
- Day Low $1.46
- Day High $1.54
- Year High $1.75
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/03/2024
- Fiscal Year End N/A
- Average Stock Price Target $3.50
- High Stock Price Target $4.00
- Low Stock Price Target $3.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.35
- Trailing P/E Ratio -3.69
- Forward P/E Ratio -3.69
- P/E Growth -3.69
- Net Income $-188,863,000
Income Statement
Quarterly
Annual
Latest News of OPK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Johns Hopkins To Require SAT/ACT Scores For 2025-26 Admissions Cycle, Following Stanford
Johns Hopkins University and Stanford University have reinstated SAT/ACT requirements for undergraduate admissions. This move follows a review showing the value of standardized testing in predicting a...
By Forbes | 2 weeks ago -
Book Review: Ellen Hopkins' new novel 'Sync' is a stirring story of foster care through teens' eyes
Ellen Hopkins' novel "Sync" skillfully blends prose and poetry to depict the challenges faced by twins in the foster system....
By AP NEWS | 3 weeks ago -
Weekend To Do List: Hopkinton, N.H. State Fair, plus sunflower and tomato festivals
Enjoy the end of summer in New England with a state fair and festivals dedicated to sunflowers and tomatoes. Join Felix's Family Farm in Ipswich for a Sunflower Festival, the 107th annual Hopkinton St...
By CBS News | 4 weeks ago
